Atlas Venture is systematically unwinding a large position built since 2020. The proposed 76,650 shares is a small continuation of a much larger weekly pace ($15-57M/day June 22-26). Monitor for additional 144s if Atlas intends to dispose of its remaining stake. The ongoing selling is a technical overhang but not a negative signal on Kymera's business fundamentals given the 93% analyst buy consensus and strong institutional ownership.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 30 $114.67entry
- T+1 · 5mo ago −0.41%α −0.27% · $114.20
- T+5 · 4mo ago +0.08%α −0.53% · $114.76
- T+20 · 4mo ago −4.03%α −3.00% · $110.05
- T+60 · 8w ago +0.70%α −2.87% · $115.47
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Atlas Venture, a founding VC investor in Kymera Therapeutics, has filed two Form 144 notices to sell a combined 76,650 shares of common stock valued at approximately $8.3M (~0.09% of market cap). These filings follow a remarkable 9 consecutive days of heavy Atlas Venture selling (April through late June 2026) totaling over 1.6 million shares worth ~$157M, as disclosed in the same filing's recent transaction history. The selling is part of a systematic, pre-planned secondary distribution by a venture fund that owned the shares since a 2020 private placement and is well past its standard lock-up. While the 76,650 share amount is small relative to the prior week's pace (>1.4M shares sold June 17-26), the filings confirm Atlas continues to monetize its position in an orderly manner. This does not reflect management's view of the business, Kymera has 93% analyst buy ratings and a $9.4B market cap, but the persistent supply overhang is a real technical factor.
Key Facts
- Atlas Venture Fund X, L.P. filed Form 144 to sell 66,177 shares at ~$7.16M.
- Atlas Venture Opportunity Fund I, L.P. filed Form 144 to sell 10,473 shares at ~$1.13M.
- Combined proposed sale: 76,650 shares worth ~$8.29M (0.09% of $9.4B market cap).
- Filings disclose Atlas Venture funds sold over 1.6 million shares between June 17-26, 2026 totaling ~$157M.
- Shares were originally acquired in a private placement on March 11, 2020, well beyond any lock-up.
- The seller is Atlas Venture, a founding venture capital investor, not company management.
Financial Impact
Proposed sale of ~$8.3M, part of a much larger $157M selling program over 9 trading days in June 2026
Risk Factors
- Continued Atlas Venture selling could pressure the stock in the near term regardless of fundamentals
- Liquidity risk: if Atlas accelerates selling, the stock may struggle to absorb the supply
- No cross-filing context to suggest any negative catalyst, this is pure VC distribution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (KYMR), Batch item 1 | 0001628280-26-046098 |
| Document: 0001628280-26-046098-index.html | 0001628280-26-046097 |
| Document: 0001628280-26-046098.txt | 0001628280-26-046098 |
| 144 Filing (KYMR), Batch item 4 | 0001628280-26-046097 |
| Document: 0001628280-26-046097-index.html | 0001628280-26-046098 |
| Document: 0001628280-26-046097.txt | 0001628280-26-046098 |
Track record
37 reports on KYMR
7 of 12 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 9 of 14 went positive at some point.
Filters
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $127.09 Now $125.85 −0.98% settles Dec 2
- Oct 29, 202618d ago 8-K Neutral 5/10 No price data
- Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 Now $125.85 −2.65% settles Nov 27
- Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 Now $125.85 +2.65% settles Nov 27
- Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 Now $125.85 +13.53% settles Nov 20
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 Now $125.85 +19.31% ▲ +12.47% +13.07% vs SPY
- Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 Now $125.85 −10.24% ▲ +7.60% +10.88% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 Now $125.85 −9.66% ▲ +12.59% +13.44% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers